The vascular access questionnaire: a single centre UK experience
Abstract Background Haemodialysis is capable of prolonging life in patients with end stage renal disease, however this therapy comes with significant negative impact on quality of life. For patients requiring haemodialysis, the need for an adequately functioning vascular access (VA) is an everyday c...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-08-01
|
| Series: | BMC Nephrology |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12882-019-1493-9 |
| _version_ | 1819157964345311232 |
|---|---|
| author | M. Field A.Z Khawaja J. Ellis T. Nieto J. Hodson N. Inston |
| author_facet | M. Field A.Z Khawaja J. Ellis T. Nieto J. Hodson N. Inston |
| author_sort | M. Field |
| collection | DOAJ |
| description | Abstract Background Haemodialysis is capable of prolonging life in patients with end stage renal disease, however this therapy comes with significant negative impact on quality of life. For patients requiring haemodialysis, the need for an adequately functioning vascular access (VA) is an everyday concern. The Vascular Access Questionnaire (VAQ) provides a mechanism for identifying and scoring factors in haemodialysis that impact on patients’ quality of life and perception of their therapy. Methods Between April 2017–18 the VAQ was administered to prevalent haemodialysis patients at 10 units in the West Midlands via structured interviews. Results 749 of 920 potentially eligible patients completed the survey. The mean VAQ score was seen to improve significantly with age (7.7 in < 55 vs. 3.8 in 75+) and the duration of access (8.9 if less than 1 month old vs. 5.0 at a year). Better average scores were demonstrated for Arteriovenous fistulas (AVF) than other modalities (AVF 5.1 vs. AVG (arteriovenous grafts) 7.2 vs. CVC (central venous catheter) 6.6). There was no significant difference in scores between fistulas on non-dominant or dominant arms, with both having a mean of 5.2 (p = 0.341). Conclusions Overall, better satisfaction scores were seen in AVF. The presence of an AVF on the non-dominant arm was not a concern for the majority of patients and did not affect the VAQ score. A number of factors were identified that can influence VAQ satisfaction score. |
| first_indexed | 2024-12-22T16:17:08Z |
| format | Article |
| id | doaj.art-269c4b2bb7104866808d8766e8002c05 |
| institution | Directory Open Access Journal |
| issn | 1471-2369 |
| language | English |
| last_indexed | 2024-12-22T16:17:08Z |
| publishDate | 2019-08-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Nephrology |
| spelling | doaj.art-269c4b2bb7104866808d8766e8002c052022-12-21T18:20:21ZengBMCBMC Nephrology1471-23692019-08-0120111310.1186/s12882-019-1493-9The vascular access questionnaire: a single centre UK experienceM. Field0A.Z Khawaja1J. Ellis2T. Nieto3J. Hodson4N. Inston5Department of Renal Transplantation and Vascular Access Surgery, Queen Elizabeth HospitalDepartment of Renal Transplantation and Vascular Access Surgery, Queen Elizabeth HospitalDepartment of Renal Transplantation and Vascular Access Surgery, Queen Elizabeth HospitalDepartment of Renal Transplantation and Vascular Access Surgery, Queen Elizabeth HospitalInstitute of Translational Medicine, Queen Elizabeth HospitalDepartment of Renal Transplantation and Vascular Access Surgery, Queen Elizabeth HospitalAbstract Background Haemodialysis is capable of prolonging life in patients with end stage renal disease, however this therapy comes with significant negative impact on quality of life. For patients requiring haemodialysis, the need for an adequately functioning vascular access (VA) is an everyday concern. The Vascular Access Questionnaire (VAQ) provides a mechanism for identifying and scoring factors in haemodialysis that impact on patients’ quality of life and perception of their therapy. Methods Between April 2017–18 the VAQ was administered to prevalent haemodialysis patients at 10 units in the West Midlands via structured interviews. Results 749 of 920 potentially eligible patients completed the survey. The mean VAQ score was seen to improve significantly with age (7.7 in < 55 vs. 3.8 in 75+) and the duration of access (8.9 if less than 1 month old vs. 5.0 at a year). Better average scores were demonstrated for Arteriovenous fistulas (AVF) than other modalities (AVF 5.1 vs. AVG (arteriovenous grafts) 7.2 vs. CVC (central venous catheter) 6.6). There was no significant difference in scores between fistulas on non-dominant or dominant arms, with both having a mean of 5.2 (p = 0.341). Conclusions Overall, better satisfaction scores were seen in AVF. The presence of an AVF on the non-dominant arm was not a concern for the majority of patients and did not affect the VAQ score. A number of factors were identified that can influence VAQ satisfaction score.http://link.springer.com/article/10.1186/s12882-019-1493-9Vascular accessPatient reported outcomesVascular access questionnairePatient experience |
| spellingShingle | M. Field A.Z Khawaja J. Ellis T. Nieto J. Hodson N. Inston The vascular access questionnaire: a single centre UK experience BMC Nephrology Vascular access Patient reported outcomes Vascular access questionnaire Patient experience |
| title | The vascular access questionnaire: a single centre UK experience |
| title_full | The vascular access questionnaire: a single centre UK experience |
| title_fullStr | The vascular access questionnaire: a single centre UK experience |
| title_full_unstemmed | The vascular access questionnaire: a single centre UK experience |
| title_short | The vascular access questionnaire: a single centre UK experience |
| title_sort | vascular access questionnaire a single centre uk experience |
| topic | Vascular access Patient reported outcomes Vascular access questionnaire Patient experience |
| url | http://link.springer.com/article/10.1186/s12882-019-1493-9 |
| work_keys_str_mv | AT mfield thevascularaccessquestionnaireasinglecentreukexperience AT azkhawaja thevascularaccessquestionnaireasinglecentreukexperience AT jellis thevascularaccessquestionnaireasinglecentreukexperience AT tnieto thevascularaccessquestionnaireasinglecentreukexperience AT jhodson thevascularaccessquestionnaireasinglecentreukexperience AT ninston thevascularaccessquestionnaireasinglecentreukexperience AT mfield vascularaccessquestionnaireasinglecentreukexperience AT azkhawaja vascularaccessquestionnaireasinglecentreukexperience AT jellis vascularaccessquestionnaireasinglecentreukexperience AT tnieto vascularaccessquestionnaireasinglecentreukexperience AT jhodson vascularaccessquestionnaireasinglecentreukexperience AT ninston vascularaccessquestionnaireasinglecentreukexperience |